Loading
Latest filing published 30 Dec 2025 for Medexus Pharmaceuticals Inc., €6,392.
No signal scores available.
Only one filing by Benoit Gravel is known so far (30 December 2025): an option exercise, €6,392, in Medexus Pharmaceuticals Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration